BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1105558)

  • 21. Determination of middle molecules in uremic patients.
    Wu ZG; Cai ZH; Lu ZN; Liao LT; Zhu SQ
    Chin Med J (Engl); 1985 Feb; 98(2):115-20. PubMed ID: 3922688
    [No Abstract]   [Full Text] [Related]  

  • 22. Improved separation and quantification of the "middle molecule" b4-2 in uremia.
    Faguer P; Man NK; Cueille G; Di Giulio S; Funck-Brentano JL
    Clin Chem; 1983 Apr; 29(4):703-7. PubMed ID: 6831703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Determination of "middle molecules" presenting vitamin B12 molecular size in normal and uremic body fluids (author's transl)].
    Cueille G
    J Chromatogr; 1978 Jul; 146(1):55-65. PubMed ID: 670358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What causes toxicity in uraemia?
    Br Med J; 1977 Jul; 2(6080):143-4. PubMed ID: 871815
    [No Abstract]   [Full Text] [Related]  

  • 25. [Uremic toxins. Chromatographic profiles of substances of low and medium molecular weight].
    Nesse AB; Arrizurieta de Muchnik E
    Medicina (B Aires); 1984; 44(2):117-26. PubMed ID: 6537452
    [No Abstract]   [Full Text] [Related]  

  • 26. [Study of toxic activity of blood in uremia].
    Shumakov VI; Gabriélian NI; Shcherbaneva OI; Dmitriev AA; Mogireva IA
    Ter Arkh; 1980; 52(4):62-4. PubMed ID: 7404340
    [No Abstract]   [Full Text] [Related]  

  • 27. The road toward the identification of middle molecules. Preliminary Committee Meeting, Avignon, France November 28-29, 1980.
    Bergstrom J; Funck-Brentano JL; Klinkmann H
    Artif Organs; 1980 Aug; 4(3):209-10. PubMed ID: 7417037
    [No Abstract]   [Full Text] [Related]  

  • 28. Middle molecules as a marker of uremic toxins.
    Wu ZG; Liao LT; Cai ZH; Lu ZN; Cai YD; Sheng PF
    Adv Exp Med Biol; 1987; 223():33-7. PubMed ID: 3447449
    [No Abstract]   [Full Text] [Related]  

  • 29. The elusive middle molecule?
    Hattler BG
    Proc Clin Dial Transplant Forum; 1973; 3():130-4. PubMed ID: 4283132
    [No Abstract]   [Full Text] [Related]  

  • 30. The pathogenesis and consequences of AGE formation in uraemia and its treatment.
    Dawnay A; Millar DJ
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1081-94. PubMed ID: 9846890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Uremic middle-molecule toxins and their removal in hemofiltration].
    Kazakov IV; Timokhov VS
    Urol Nefrol (Mosk); 1991; (1):67-73. PubMed ID: 1858215
    [No Abstract]   [Full Text] [Related]  

  • 32. Extracorporeal strategies for the removal of middle molecules.
    Winchester JF; Audia PF
    Semin Dial; 2006; 19(2):110-4. PubMed ID: 16551287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uremic middle molecules: analytical study of middle molecular weight fractions subpeak b4-2.
    Le Moel G; Strecker G; Cueille G; Boudet J; Man NK; Galli A; Agneray J
    Artif Organs; 1981; 4 Suppl():17-21. PubMed ID: 7295087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ["Middle molecules" as nonspecific regulators of phagocyte activity].
    Volchegorskiĭ IA; Vlasov AV; Livshits GE; Akhkiamov EM; Skobeleva NA; Lifshits RI; Ebert LIa
    Biull Eksp Biol Med; 1995 Feb; 119(2):159-62. PubMed ID: 7670039
    [No Abstract]   [Full Text] [Related]  

  • 35. [Depurative efficiency of intermediate and large molecules with different hemodialysis modalities].
    Maduell F
    Nefrologia; 2005; 25 Suppl 2():15-8. PubMed ID: 16050396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transport of small, middle, and large molecular weight substances in a dual filtration artificial kidney.
    Smeby LC; Jörstad S; Wideröe TE; Svartaas TM
    Artif Organs; 1981; 4 Suppl():104-9. PubMed ID: 7295075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A bench to bedside view of uremic toxins.
    Vanholder R; Baurmeister U; Brunet P; Cohen G; Glorieux G; Jankowski J;
    J Am Soc Nephrol; 2008 May; 19(5):863-70. PubMed ID: 18287557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood level of middle molecular substances during uraemia and haemodialysis.
    Dzúrik R; Bozek P; Reznícek J; Oborníková A
    Proc Eur Dial Transplant Assoc; 1973; 10(0):263-70. PubMed ID: 4802412
    [No Abstract]   [Full Text] [Related]  

  • 39. Separation, isolation, and identification of middle molecules.
    Bergström J; Fürst P; Zimmerman L
    Artif Organs; 1981; 4 Suppl():5-7. PubMed ID: 7295096
    [No Abstract]   [Full Text] [Related]  

  • 40. The synthesis of middle molecular substances in rat tissues: in vitro study.
    Dzúrik R; Cernácek P; Spustová V; Válek A
    Proc Eur Dial Transplant Assoc; 1978; 15():633-5. PubMed ID: 740703
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.